Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y. Ho, Eugene Braunwald, Sharlene M. Day et al.|Nature Medicine|2021Cited by 132
A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK)Shohreh Honarbakhsh, Pier D. Lambiase, Ross J. Hunter et al.|JACC. Clinical electrophysiology|2020Cited by 94